Lee, S., Shah, T., Yin, C., Hochberg, J., Ayello, J., Morris, E., . . . Cairo, M. S. (2018). Ruxolitinib significantly enhances in vitro apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine model. Oncotarget.
Citação norma ChicagoLee, Sanghoon, Tishi Shah, Changhong Yin, Jessica Hochberg, Janet Ayello, Erin Morris, Carmella van de Ven, and Mitchell S. Cairo. "Ruxolitinib Significantly Enhances in Vitro Apoptosis in Hodgkin Lymphoma and Primary Mediastinal B-cell Lymphoma and Survival in a Lymphoma Xenograft Murine Model." Oncotarget 2018.
MLA CitationLee, Sanghoon, et al. "Ruxolitinib Significantly Enhances in Vitro Apoptosis in Hodgkin Lymphoma and Primary Mediastinal B-cell Lymphoma and Survival in a Lymphoma Xenograft Murine Model." Oncotarget 2018.